2. Gene
  3. C6 - complement C6 Gene

C6 - complement C6 Gene

  • 基因
  • 蛋白
  • 疾病
  • 相关产品
  • 直系同源

中文名称：补体 C6

种属: Homo sapiens

基因 ID: 729 | 基因类型: protein coding

关于 C6

Cytogenetic location: 5p13.1 Genomic coordinates (GRCh38): 5:41,142,116-41,261,469 (from NCBI)

This gene has 9 transcripts (splice variants), 206 orthologues, 39 paralogues and is associated with 2 phenotypes. Biased expression in liver (RPKM 126.4), heart (RPKM 11.8) and 2 other tissues.

功能概要

该基因编码补体级联的一个组成部分。编码的蛋白质是膜攻击复合物的一部分，可以掺入细胞膜并引起细胞裂解。该基因的突变与补体成分 6 缺乏有关。已经描述了编码相同蛋白质的转录变体。[RefSeq 提供，2012 年 11 月]

This gene encodes a component of the complement cascade. The encoded protein is part of the membrane attack complex that can be incorporated into the cell membrane and cause Cell Lysis. Mutations in this gene are associated with complement component-6 deficiency. Transcript variants encoding the same protein have been described.[provided by RefSeq, Nov 2012]

C6 基因产物(2)

mRNA Protein Name
NM_000065.5 NP_000056.2 complement component C6 precursor
NM_001115131.4 NP_001108603.2 complement component C6 precursor
基因本体论
  • 分子功能
  • 生物过程
  • 细胞组分
分子功能 GO 注释 逻辑证据 参考文献 来源
enables protein binding IPI
IPI: 通过物理相互作用推断
17474147 GOA
生物过程 GO 注释 逻辑证据 参考文献 来源
involved in complement activation IDA
IDA: 通过直接分析推断
2808363 GOA
细胞组分 GO 注释 逻辑证据 参考文献 来源
part of membrane attack complex IDA
IDA: 通过直接分析推断
22832194 GOA
part of membrane attack complex IPI
IPI: 通过物理相互作用推断
30552328 GOA
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断

C6 蛋白结构

TSP_1

TSP_1: Thrombospondin type 1 domain (28 - 78)

TSP_1

TSP_1: Thrombospondin type 1 domain (86 - 133)

Ldl_recept_a

Ldl_recept_a: Low-density lipoprotein receptor domain class A (140 - 173)

MACPF

MACPF: MAC/Perforin domain (293 - 514)

TSP_1

TSP_1: Thrombospondin type 1 domain (571 - 612)

Sushi

Sushi: Sushi repeat (SCR repeat) (644 - 695)

Sushi

Sushi: Sushi repeat (SCR repeat) (713 - 754)

Kazal_2

Kazal_2: Kazal-type serine protease inhibitor domain (793 - 837)

  • 0
  • 200
  • 400
  • 600
  • 800
  • 934 a.a.
蛋白主名 其他名称

complement component C6

complement component 6

C6 蛋白互作信息

分类
蛋白名称 蛋白编号 互作蛋白 互作蛋白种属 互作蛋白编号 实验方法 参考文献
种属内
C6 P13671 NCK1 Homo sapiens P16333
Peptide Array
17474147
种属间: 跨种属相互作用 种属内: 同种属相互作用

重组 C6 蛋白

目录号 产品名 蛋白编号 纯度
HY-P74373 C6/Complement component C6 Protein, Human (HEK293, His) AAA59668 (C22-A934) ≥95%

关联疾病

疾病名称 别名
Complement Component 6 Deficiency

C6 Deficiency

C6D

C6 Deficiency Subtotal

Complement Component 6 Deficiency Subtotal

C6 Deficiency, Subtotal
Immunodeficiency Due To A Late Component Of Complement Deficiency

Immunodeficiency Due To C5 To C9 Component Complement Deficiency

Terminal Complement Pathway Deficiency
Meningococcal Meningitis

Meningitis, Meningococcal

Meningitis Meningococcal

Epidemic Meningitis

Meningitis Due To Neisseria Meningitidis

Meningococcal Meninges Infection

Meningococcal Meningeal Infection

Meningococcal Cerebrospinal Inflammation

Chronic Meningococcal Arachnoiditis

Meningococcal Arachnoiditis

Diplococcal Spinal Meningitis

Diplococcal Meningitis

Meningococcal Cerebrospinal Fever

Meningococcal Cerebrospinal Infection

Meningococcal Spinal Meningitis
疾病名称 别名
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

相关产品

Approval
生物活性分子 (1)
目录号 产品名 作用方式
纯度 是否罕见病
HY-N7140 Gamma-Linolenic acid Inhibitor 99.86% 否
Clinical Phase
生物活性分子 (4)
目录号 产品名 作用方式
纯度 Phase
HY-W747264 P-Hydroxybenzaldehyde-13C6 / Phase 4
HY-104036 IDH-305 Inhibitor 99.15% Phase 2
HY-N2037A Higenamine hydrochloride 99.52% Phase 1
HY-N2037 Higenamine 98.91% Phase 1
Pre-clinical Phase
生物活性分子 (771)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-B0389A D-Glucose-13C6 99.93% 否
HY-129047 Trypsin Activator 91.00% 否
HY-16594 Lactacystin 98.20% 否
HY-19542 C6 Ceramide Inducer 99.82% 否
HY-111997 VH285-PEG4-C4-Cl ≥98.0% 否
HY-N7264 7α-Hydroxycholesterol Inhibitor 99.99% 否
HY-129047A Trypsin (MS grade) Activator 95.00% 否
HY-D0180 18-Crown-6-ether 99.77% 否
HY-N0455AS8 L-Arginine-13C6,15N4 hydrochloride Activator 99.85% 否
HY-140921 Biotin-PEG4-amino-t-Bu-DADPS-C6-azide 95.0% 否
HY-N1428S1 Citric acid-13C6 99.90% 否
HY-N0455AS6 L-Arginine-13C6 hydrochloride Activator 99.00% 否
HY-N1127 Tricin Inhibitor 99.82% 否
HY-N7092S D-Fructose-13C6 99.95% 否
HY-W011561 Boc-NH-C6-Br 98.0% 否
HY-107836 Methiothepin mesylate Antagonist 99.60% 否
HY-100014 KDM5A-IN-1 Inhibitor 99.64% 否
HY-145442 8-Azanebularine Inhibitor 99.33% 否
HY-133685 N-Hexanoyl-L-homoserine lactone Modulator 98.82% 否
HY-140914 Biotin-PEG4-Amide-C6-Azide 99.11% 否
HY-N0470S3 L-Lysine-13C6,15N2 hydrochloride Inhibitor 99.87% 否
HY-N0215S8 L-Phenylalanine-13C6 Antagonist 99.8% 否
HY-W008296 NH2-C6-NH-Boc 99.61% 否
HY-W356116 C6 NBD Ceramide 99.33% 否
HY-N0486S8 L-Leucine-13C6,15N Activator 99.90% 否
HY-112537S1 D-Glucose 6-Phosphate-13C6 disodium xhydrate 99.6% 否
HY-140314 DOTA-PEG5-C6-DBCO 96.27% 否
HY-N0486S2 L-Leucine-13C6 Activator 99.64% 否
HY-N6974 Ascr#2 98.0% 否
HY-139218 (S,R,S)-AHPC-Me-C6-NH2 99.81% 否
HY-B0322S1 Sulfamethoxazole-13C6 Inhibitor 99.80% 否
HY-W009762S L-Lysine-13C6,15N2 dihydrochloride 99.40% 否
HY-111253 CYM-5478 Agonist 99.90% 否
HY-129622A NH2-PEG5-C6-Cl hydrochloride 98.0% 否
HY-W356117 C6 NBD Glucosylceramide 98.0% 否
HY-W014375S2 DL-Arginine-13C6 hydrochloride 99.00% 否
HY-133689AS 3-Nitrophenylhydrazine-13C6 hydrochloride 98.26% 否
HY-111753A WDR5-IN-4 TFA 98.04% 否
HY-N0771S L-Isoleucine-13C6 99.77% 否
HY-111753 WDR5-IN-4 98.13% 否
HY-112496 Cl-C6-PEG4-O-CH2COOH 98.0% 否
HY-138470 Azido-PEG2-C6-Cl 95.0% 否
HY-138521 Azido-C6-OH 98.0% 否
HY-N0379S22 D-Mannose-13C6 98.0% 否
HY-N0167 Gynostemma Extract Inhibitor 99.92% 否
HY-N0210S16 D-Galactose-13C6 99.0% 否
HY-N0473S2 L-Tyrosine-13C6 99.90% 否
HY-114118S3 Semaglutide-13C6,15N TFA 96.04% 否
HY-114165 DJ-V-159 Agonist 99.94% 否
HY-B0166S L-Ascorbic acid-13C6 99.90% 否
HY-112495 VH032-PEG5-C6-Cl 99.93% 否
HY-103605 (S,R,S)-AHPC-C6-PEG3-C4-Cl 97.01% 否
HY-B0143S3 Niacin-13C6 Inducer 99.90% 否
HY-138466 Azido-PEG3-C6-Cl 95.30% 否
HY-161536 PROTAC EGFR degrader 9 98.35% 否
HY-D1574 C6 NBD Sphingomyelin 98.0% 否
HY-N2038 3,​5,​6,​7,​8,​3',​4'-​Heptemthoxyflavone Inhibitor 99.86% 否
HY-N6076 Tenuifoliside A Inhibitor 98.07% 否
HY-18569S4 3-Indoleacetic acid-13C6 99.76% 否
HY-15330 Vitamin D2-d3 Activator 98.57% 否
HY-135250B Thalidomide-4-O-C6-NH2 hydrochloride Inducer 98.53% 否
HY-141576 C6-NBD Sphinganine 99.0% 否
HY-B0400S16 D-Sorbitol-13C6 99.94% 否
HY-119402 TP-021 Inhibitor 99.14% 否
HY-130951 Thalidomide-O-C6-COOH Inducer 99.29% 否
HY-121805 DBCO-​C6-​acid 98.89% 否
HY-131089 MC-VC-PABC-C6-α-Amanitin 98.88% 否
HY-138469 NH2-PEG3-C6-Cl / 否
HY-N0469S1 L-Lysine-13C6 dihydrochloride Inhibitor 98.70% 否
HY-P3146S FTISADTSK-13C6,15N2 TFA 96.04% 否
HY-113248S1 3-Nitro-L-tyrosine-13C6 95.0% 否
HY-N0086S1 N6-Methyladenosine-13C 99.9% 否
HY-P1032S2 Angiotensin I-13C6,15N (human, mouse, rat) TFA 99.76% 否
HY-N0733S3 Glucosamine-6-13C hydrochloride 98.0% 否
HY-126683 Mal-C6-α-Amanitin 98.48% 否
HY-113296S Indoxyl sulfate-13C6 potassium 98.77% 否
HY-136006B (S,R,S)-AHPC-C6-NH2 98.03% 否
HY-137905 Pomalidomide-amido-C5-PEG2-C6-chlorine 99.69% 否
HY-155262 Pomalidomide-5-C6-NH2 hydrochloride 98.46% 否
HY-B0389S D-Glucose-13C6,d7 98.0% 否
HY-B0451AS1 Dopamine-13C6 hydrochloride 98.71% 否
HY-N0684S3 Vitamin K1-13C6 ≥99.0% 否
HY-B0252S2 Hydrochlorothiazide-13C6 99.61% 否
HY-D2527 Biotin-PEG4-amide-PEG2-C6-Cl 96.0% 否
HY-N0771S9 L-Isoleucine-13C6,15N 98.0% 否
HY-148129 Apecotrep Inhibitor 99.17% 否
HY-132004 Tos-O-C4-NH-Boc 97.03% 否
HY-143876S L-Argininosuccinic acid-13C6,15N4 barium, dihydrate 95.7% 否
HY-150012S1 N-Lactoyl-Phenylalanine-13C6 98.47% 否
HY-B0493S1 Niflumic acid-13C6 Inhibitor 99.8% 否
HY-N0470S8 L-Lysine-13C6 hydrochloride 98.0% 否
HY-N2461 Ganoderic acid C6 99.40% 否
HY-W018291 Mal-C6-amine TFA 99.73% 否
HY-13948BS Angiotensin II human-13C6,15N TFA 98.11% 否
HY-I0210S 4-Iodoaniline-13C6 99.17% 否
HY-N0098S2 Vanillin-13C6 ≥99.0% 否
HY-W014423S3 L-Histidine-13C6,15N3 hydrochloride hydrate 99.53% 否
HY-W017522S1 Adipic acid-13C6 Inhibitor 98.0% 否
HY-Y0051S 5-Hydroxymethylfurfural-13C6 Inhibitor 98.0% 否
HY-112618A Thalidomide-O-amido-C6-NH2 TFA Inducer 99.82% 否
HY-W768336 Gluconate-13C6 sodium 99.95% 否
HY-103608 (S,R,S)-AHPC-(C3-​PEG)​2-​C6-​Cl 99.89% 否
HY-10715 SSR504734 Inhibitor 99.42% 否
HY-108971 Demecycline Inhibitor 98.0% 否
HY-117042 Biotin-PEG2-C6-azide 95.87% 否
HY-129704B Thalidomide-NH-C6-NH2 hydrochloride Inducer 99.62% 否
HY-131887 Pomalidomide-C6-COOH 98.02% 否
HY-135306 Cl-C6-PEG4-C3-COOH 99.65% 否
HY-144085S D-Fructose-6-phosphate-13C6 disodium x.hydrate 99.90% 否
HY-148556 Thalidomide-O-C6-azide Inducer 99.10% 否
HY-15036S1 Diclofenac-13C6 99.90% 否
HY-161766 L687 Activator 99.49% 否
HY-16938S 5'-Methylthioadenosine-13C6 98.45% 否
HY-23641 NH-bis(C1-Boc) 99.78% 否
HY-B0497S1 Niclosamide-13C6 Inhibitor 99.0% 否
HY-B1221S1 Flufenamic acid-13C6 99.5% 否
HY-D1432 FITC-C6-DEVD-FMK ≥97.0% 否
HY-W010042S3 L-Glucose-13C6 99.43% 否
HY-W017387S2 Sodium α-ketoisocaproic acid-13C6 99.3% 否
HY-W768340 Sucrose-13C6-1 99.90% 否
HY-Y0264S 4-Hydroxybenzoic acid-13C6 99.9% 否
HY-141939S Liothyronine-13C6 hydrochloride 96.74% 否
HY-153785 NH2-C6-ARC186 sodium Inhibitor 92.50% 否
HY-159192S SADDNIKTPAE(Arg-13C6,15N4)LLGPLPPSADDNLKT TFA 97.26% 否
HY-18341S2 L-Thyroxine-13C6 91.0% 否
HY-B0166S8 L-Ascorbic acid-13C6-1 99.37% 否
HY-B0190S1 Nafamostat formate salt-13C6 98.11% 否
HY-N0216S1 Benzoic acid-13C6 Inhibitor 99.66% 否
HY-N0349S1 Methyl paraben-13C6 Inhibitor 99.90% 否
HY-P0014S2 Liraglutide-13C6,15N TFA 97.10% 否
HY-W014375S4 DL-Arginine-13C6,15N4 hydrochloride 95% 否
HY-W778225 Vanillic acid-13C6 99.90% 否
HY-129704A Thalidomide-NH-C6-NH2 TFA Inducer 99.82% 否
HY-130854 Thalidomide-NH-C6-NH-Boc Inducer 96.11% 否
HY-136006A (S,R,S)-AHPC-C6-NH2 hydrochloride / 否
HY-W014423S2 L-Histidine-13C6 hydrochloride hydrate 98.00% 否
HY-108226S1 Regorafenib N-oxide and N-desmethyl (M5)-13C6 ≥91.0% 否
HY-108372 Boc-C5-O-C5-O-C6-Cl / 否
HY-112499S1 Menaquinone-7-13C6 96.0% 否
HY-112618B Thalidomide-O-amido-C6-NH2 hydrochloride Inducer 99.32% 否
HY-124377 SPDP-C6-NHS ester 98.09% 否
HY-130621 OTs-C6-OBn 98.07% 否
HY-131682 3-C6-NBD-cholesterol 99.0% 否
HY-133694S 2-Aminoflubendazole-13C6 99.8% 否
HY-13690S1 Mitotane-13C6 98.62% 否
HY-141887 Thalidomide-O-C6-NHBoc Inducer 95.99% 否
HY-144677 pan-HER-IN-2 98.10% 否
HY-145245 TLR4-IN-C34-C2-amide-C6-OH Inhibitor 99.62% 否
HY-147622 GLP-1R agonist 9 Agonist / 否
HY-173076A HDAC11-IN-1 TFA Inhibitor 99.25% 否
HY-176258S Growth Hormone 22, Arg-13C6,15N4, Lys-13C6,15N2 95.0% 否
HY-78131S3 Ibuprofen-13C6 98.24% 否
HY-90009D (6S,12aR)-Tadalafil Inhibitor 99.34% 否
HY-A0070AS2 Liothyronine-13C6-1 Agonist 98.06% 否
HY-B0150S2 Nicotinamide-13C6 Inhibitor 99.8% 否
HY-B0167S1 Salicylic acid-13C6 97.0% 否
HY-B0892S3 Benzyl alcohol-13C6 98% 否
HY-B0925S Oxacillin-13C6 sodium Inhibitor 99% 否
HY-B0975S Penicillin V-13C6 potassium Inhibitor 99.8% 否
HY-B1267S1 Sulfaguanidine-13C6 Inhibitor 99.0% 否
HY-B1431S1 Butylparaben-13C6 99.75% 否
HY-D1575 C6 NBD Galactosylceramide / 否
HY-D1577 C6 NBD Lactosylceramide 98.0% 否
HY-N0304S1 L-DOPA-13C6 ≥98.0% 否
HY-N0378S2 D-Mannitol-13C6 98.0% 否
HY-N0384S3 Homovanillic acid-13C6,18O 99.2% 否
HY-N6612S D-Glucuronic acid sodium monohydrate-13C6 99.9% 否
HY-N9454 Garcinoic acid / 否
HY-W014225S 3-Phenoxybenzoic acid-13C6 Inducer 99.29% 否
HY-W015198S 4-(Trifluoromethyl)benzoic acid-13C6 98.31% 否
HY-W041171S 3-Chloro-L-tyrosine-13C6 97.6% 否
HY-W129359 11β-HSD1-IN-8 95.0% 否
HY-106950S1 Fosfructose-13C6 tetrasodium hydrate 99.90% 否
HY-138622S 24:0 Lyso PC-13C6 97.5% 否
HY-148124 6-epi Doxycycline Control 98.47% 否
HY-152039S1 6PPD-Q-13C6 ≥98.0% 否
HY-15550S1 4'-Hydroxy diclofenac-13C6 / 否
HY-159193S DHATS(Leu-13C6,15N)PVTIPSAVST(Gly-13C2,15N)HTTPLPVTDT TFA 97.61% 否
HY-175067 PtdIns-(4,5)-P2 (1,2-dihexanoyl) sodium salt 98.1% 否
HY-176034S GPAGPQGP-Arg(13C6,15N4) TFA 99.58% 否
HY-B0035S2 Sulfamethazine-13C6 99.10% 否
HY-B0122S Topiramate-13C6 99.67% 否
HY-B1703S Nifursol-13C6 Inhibitor 99.60% 否
HY-N0455AS4 L-Arginine-13C6,15N4,d7 hydrochloride Activator 96.00% 否
HY-N7032S1 Uridine 5′-diphosphoglucose-13C6 disodium 98.35% 否
HY-P0090S Calcitonin-13C6,15N4 (salmon) TFA Agonist / 否
HY-P3003S Cereulide-13C6 97.0% 否
HY-W014901S Bisphenol F-13C6 98.32% 否
HY-W103245 Benzo-18-crown-6-ether 99.37% 否
HY-W104010S 2-Chloroaniline hydrochloride-13C6 99.64% 否
HY-W245508 Hexylamine 99.83% 否
HY-W585956 Triclocarban-13C6 99.23% 否
HY-W653962 Triclosan-13C6 99.51% 否
HY-W653994 Ethyl Paraben-13C6 99.65% 否
HY-W654020 Propyl paraben-13C6 99.99% 否
HY-W770434 Octrizole-13C6 ≥97.0% 否
HY-W782153 Acetophenone-13C6 98.42% 否
HY-101064S1 Fmoc-leucine-13C6,15N Modulator 99.90% 否
HY-10450S5 Dapagliflozin-13C6-1 Inhibitor / 否
HY-112618 Thalidomide-O-amido-C6-NH2 Inducer / 否
HY-129704 Thalidomide-NH-C6-NH2 Inducer / 否
HY-129974S 3,3'-Diiodo-L-thyronine-13C6 / 否
HY-135250 Thalidomide-4-O-C6-NH2 Inducer / 否
HY-135250A Thalidomide-4-O-C6-NH2 TFA Inducer / 否
HY-136006 (S,R,S)-AHPC-C6-NH2 dihydrochloride / 否
HY-19542S Ceramide C6-d7 Inducer 99.0% 否
HY-B0221S Amphotericin B-13C6 Inhibitor / 否
HY-N0455AS11 L-Arginine-13C6,d14 hydrochloride / 否
HY-N0683S 2-ambo-Vitamin E-13C6 Inhibitor / 否
HY-W050145S2 Levoglucosan-13C6 / 否
HY-125884 Pomalidomide-amido-C4-amido-C6-NH-Boc / 否
HY-100532S CD437-13C6 Agonist / 否
HY-100599S2 Urolithin A-13C6 / 否
HY-10163S2 Dabigatran-13C6 / 否
HY-10260S2 Vandetanib-13C6 / 否
HY-10450S3 Dapagliflozin-13C6 / 否
HY-10572S1 Efavirenz-13C6 / 否
HY-106950CS3 Fosfructose-6-13C sodium / 否
HY-109120S1 Odevixibat-13C6 Inhibitor / 否
HY-10999S1 Trametinib-13C6 / 否
HY-112586S1 Sulfaethoxypyridazine-13C6 Inhibitor / 否
HY-113251S1 2-Hydroxyestrone-13C6 Inhibitor / 否
HY-113252S1 2-Methoxyestrone-13C6 / 否
HY-113278S Leucyl-phenylalanine-13C6,15N TFA / 否
HY-113283S Homogentisic acid-13C6 / 否
HY-113407CS D-Fructose-6-phosphate disodium monohydrate-13C6 / 否
HY-114750S Mebendazole-amine-13C6 / 否
HY-114895 SSR504734 free base Inhibitor / 否
HY-115584S Lufenuron-13C6 Inhibitor / 否
HY-116214S1 Cyprodinil-13C6 / 否
HY-116585 C6 D-Threo Ceramide (d18:1/6:0) Activator / 否
HY-116609 C6 L-threo Ceramide Inhibitor / 否
HY-117275S1 Meclofenamic acid-13C6 Inhibitor / 否
HY-12008S1 Erlotinib-13C6 hydrochloride / 否
HY-12033S1 2-Methoxyestradiol-13C6 / 否
HY-122062S Fenoxycarb-13C6 / 否
HY-124489S 2-Hydroxyestradiol-13C6 / 否
HY-125296S Fipronil sulfone-13C6 / 否
HY-125888 Boc-NH-C6-amido-C4-acid / 否
HY-126373S1 SN-38 glucuronide-13C6 / 否
HY-12726S Liproxstatin-1-13C6 / 否
HY-12857S Brigatinib-13C6 Inhibitor / 否
HY-128790S1 4-Methoxyestrone-13C6 / 否
HY-129622 NH2-PEG5-C6-Cl / 否
HY-129656 GLP-1 receptor agonist 3 Agonist / 否
HY-13078S Cobimetinib-13C6 racemate Inhibitor / 否
HY-131501S1 Menaquinone-9-13C6 / 否
HY-131622S 7-Aminoclonazepam-13C6 / 否
HY-133685S N-Hexanoyl-L-Homoserine lactone-d3 Modulator / 否
HY-13443S Exendin-4 (Leu-13C6,15N) TFA / 否
HY-13613S Dutasteride-13C6 / 否
HY-136380S Clodinafop-propargyl-13C6 / 否
HY-137912S1 Resveratrol-3-O-beta-D-glucuronide-13C6 / 否
HY-138307 NH2-PEG-Strt (MW 10000) / 否
HY-138308 NH2-PEG-Strt (MW 3000) / 否
HY-138310 Thiol-PEG-COOH (MW 5000) / 否
HY-138311 Boc-NH-PEG-Thiol (MW 10000) / 否
HY-138471 Azido-PEG2-C6-OH / 否
HY-138852 Thalidomide-NH-amido-C6-NH2 Inducer / 否
HY-138852A Thalidomide-NH-amido-C6-NH2 hydrochloride Inducer / 否
HY-139062 C6 Urea Ceramide / 否
HY-141123 SPDP-C6-Gly-Leu-NHS ester / 否
HY-141315 m-PEG6-C6-phosphonic acid ethyl ester / 否
HY-141909S 4-Fluoroiodobenzene-13C6 / 否
HY-141919S 1-Bromo-4-iodobenzene-13C6 / 否
HY-141928S 4-Bromoanisole-13C6 / 否
HY-143276 (S,S,R)-AHPC-C6-NH2 / 否
HY-143276A (S,S,R)-AHPC-C6-NH2 hydrochloride 97.20% 否
HY-143830 t-Boc-N-amido-PEG2-C6-Cl / 否
HY-143843S Isosorbide-2-mononitrate-13C6 / 否
HY-144825 Chol-CTPP Inducer / 否
HY-14520S2 Tetrahydrofolic acid-13C6 / 否
HY-14538S3 Haloperidol-13C6 Antagonist / 否
HY-146002 IDH2R140Q-IN-1 Inhibitor / 否
HY-146687 BuChE-IN-4 Inhibitor / 否
HY-146807 Type II TRK inhibitor 1 Inhibitor / 否
HY-146966S 2-NP-DNSAH-13C6 / 否
HY-146967S 4-(3,6-Dimethylhept-3-yl)phenol-13C6 / 否
HY-146968S Alloerythro-Isoxsuprine-13C6 hydrochloride / 否
HY-146969S Bisdesoxyquinoceton-13C6 / 否
HY-146972S Zearalenone-14-O-β-glucoside-13C6 / 否
HY-147178 C-6 NBD-dihydro-Ceramide / 否
HY-147516 SARS-CoV-2-IN-21 Inhibitor / 否
HY-147551S 3-Iodo-L-thyronine-13C6 / 否
HY-148143 Pomalidomide-C6-NHS ester / 否
HY-148153 C6-Amide-(PEG)n-CH3 / 否
HY-148154 Poly(oxy-1,2-ethanediyl)-propoxy-amide-C6 / 否
HY-148362 Pomalidomide-C6-O-C5-O-C4-COOH 98.55% 否
HY-14894S2 Pragliflozin-13C6 Inhibitor / 否
HY-15027S2 5-Aminosalicylic acid-13C6 / 否
HY-15037S Diclofenac-13C6 sodium heminonahydrate / 否
HY-15037S2 Diclofenac-13C6 sodium / 否
HY-150626 SARS-CoV-2 nsp13-IN-5 Inhibitor / 否
HY-150703S 4-Methoxyestradiol-13C6 / 否
HY-150706S D-fructose-6-phosphate-13C6 / 否
HY-150978 DDAO-C6 / 否
HY-151271 SARS-CoV-2-IN-27 Inhibitor / 否
HY-151271A SARS-CoV-2-IN-27 disodium Inhibitor / 否
HY-151791 (S,R,S)-AHPC-C6-PEG3-butyl-N3 / 否
HY-15284S3 Prasugrel-13C6 Inhibitor / 否
HY-153542 AP-C6 Inhibitor / 否
HY-155141 hCYP3A4-IN-1 Inhibitor / 否
HY-155593 JNK-1-IN-2 Inhibitor / 否
HY-156341S1 LLIYYTSSLHSGVPSR-(Arg-13C6,15N4) (TFA) / 否
HY-156343S1 SNNYATHYAESVK-(Lys-13C6,15N2) (TFA) / 否
HY-156344S1 GLEWVAEIR-(Arg-13C6,15N4) (TFA) / 否
HY-156345S1 LPFTFGQGTK-(Lys-13C6,15N2) (TFA) / 否
HY-158251 BIBD-300 / 否
HY-158383 Pomalidomide-CO-C3-PEG4-C6-NH2 / 否
HY-158803 C6 Biotin glucosylceramide (d18:1/6:0) / 否
HY-158992S SP-(Val-13C5,15N)-EKNQ-(Leu-13C6,15N)-TIDFINIVKDPVPHNEYKT TFA / 否
HY-158994S MEGDSRGG-(Ala-13C3,15N)-GGEA-(Leu-13C6,15N)-DPESAASSLSGAS TFA / 否
HY-159017 EM-12-Alkyne-C6-OMs / 否
HY-159018 Alkyne-C6-OMs / 否
HY-161012 RB-07-16 Inhibitor / 否
HY-162295 SARS-CoV-2-IN-83 Inhibitor / 否
HY-162342 Topoisomerase I inhibitor 14 Inhibitor / 否
HY-162370 CYP51-IN-16 Inhibitor / 否
HY-162522 SL-IN-1 Inhibitor / 否
HY-162644 Antitumor agent-170 Inhibitor / 否
HY-162782A V–C6–Bg-PhCl TFA Inhibitor / 否
HY-163422S PHSHPALTPEQK-(Lys-13C6,15N2) / 否
HY-163423S TELAEPTSTR-(Arg-13C6,15N4) / 否
HY-163424S SSVFVADPK-(Lys-13C6,15N2) / 否
HY-163425S AILNYVANK-(Lys-13C6,15N2) / 否
HY-163426S AFFGHYLYEVAR-(Arg-13C6,15N4) / 否
HY-163427S FNLEALVTHTLPFEK-(Lys-13C6,15N2) / 否
HY-163986 Pomalidomide-C2-NHCO-C6 / 否
HY-16561S1 Resveratrol-13C6 / 否
HY-16561S2 (E/Z)-Resveratrol-13C6 / 否
HY-168722 PROTAC PARP1 degrader-3 Degrader / 否
HY-168724 Thalidomide-piperidine-C-Pip-C2-Pip-C2-OH Degrader / 否
HY-168944 ABCB1-IN-4 Inhibitor / 否
HY-169111 SHP2-IN-32 Inhibitor / 否
HY-169292 Antitumor agent-188 / 否
HY-170207S Aurothioglucose 70%-13C6 / 否
HY-170337 N-Me-Thalidomide-NH-C6-NH2 / 否
HY-170448 PROTAC AR Degrader-9 Degrader / 否
HY-170449 E3 ligase Ligand 48 / 否
HY-170818 Grp94 Inhibitor-3 Inhibitor / 否
HY-170926 CQ1373 / 否
HY-171509 Mal-N(Me)-C6-N(Me)-PNU-159682 Inducer / 否
HY-171896 A28-C6B2 / 否
HY-172666F C6 Biotin dihydro ceramide (d18:0/6:0) / 否
HY-173076 HDAC11-IN-1 Inhibitor / 否
HY-173538 C6 NBD Sphingomyelin (d18:1/6:0) / 否
HY-173541 C6 Dihydro 1-deoxyceramide (m18:0/6:0) / 否
HY-17376S3 Ezetimibe-13C6 / 否
HY-17453S1 Salmeterol-13C6 xinafoate Agonist / 否
HY-174880 CRBN ligand-8-O-C6-NH2 / 否
HY-175010 STAT3-IN-44 / 否
HY-175255 EGFR-IN-47-C6-COOMe / 否
HY-175440 Thalidomide-S-C6-acid / 否
HY-17596S Closantel-13C6 Inhibitor / 否
HY-17598S Rafoxanide-13C6 Inhibitor / 否
HY-176167 mTOR ligand 1-C6-amino / 否
HY-176277S Fibrinopeptide B, human-(Val-13C5,15N, Arg-13C6,15N4) TFA / 否
HY-176304S Neurofilament, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176306S Synuclein alpha, Lys-13C6,15N2 / 否
HY-176309S Tau 441, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176313S Carboxypeptidase B2, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176314S Clusterin protein, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176341S KRAS 2B G13D mutant, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176342S KRAS 2B Q61H mutant, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176344S PD1, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176345S Vitamin D Binding Protein, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176346S PDL1, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176347S Alpha Feto Protein, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176349S HRAS, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176353S KRAS 2B G13C mutant, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176354S KRAS 2B G12V mutant, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176356S KRAS 2B, Arg-13C6,15N4, Lys-13C6,15N4 / 否
HY-176357S KRAS 2B G12R mutant, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176358S KRAS 2B G12C mutant, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176359S KRAS 2B G12D mutant, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176802 Oxide-DFHBI-demethyl-C6-NH2 / 否
HY-176825 MU1742-amide-C6-acid Inhibitor / 否
HY-178178 PARP1-IN-46 / 否
HY-18341S1 Thyroxine hydrochloride-13C6 / 否
HY-18341S3 L-Thyroxine-13C6,15N / 否
HY-18341S4 L-Thyroxine-13C6-1 / 否
HY-18572S 2,4-D-13C6 Inhibitor / 否
HY-19542S1 C6 Ceramide-d11 Inducer / 否
HY-22306S β-D-Glucose pentaacetate-13C6 / 否
HY-34428S 4-Fluorobenzonitrile-13C6 / 否
HY-403978S Benzamide-C6-N-Boc-C2-amide-phenol-d5 / 否
HY-44630 VH 032 amide-alkylC6-acid / 否
HY-50896S1 Erlotinib-13C6 / 否
HY-66005S3 Acetaminophen-13C6 Inhibitor / 否
HY-66008S2 N-Acetyl mesalazine-13C6 / 否
HY-76929S tert-Butyl 4-aminobenzoate-13C6 / 否
HY-79131S Fmoc-Phe-OH-13C6 98.0% 否
HY-79576S2 Estrone 3-methyl ether-13C6 / 否
HY-A0067S1 Oxybenzone-13C6 / 否
HY-A0130S Sulfalene-13C6 Inhibitor 99.0% 否
HY-A0132S12 N-Acetyl-D-glucosamine-13C6 / 否
HY-A0161S Chlophedianol-13C6 / 否
HY-B0141S4 Estradiol-13C6 Agonist / 否
HY-B0141S7 rel-Estradiol-13C6 / 否
HY-B0152S2 Adenine-13C5,15N5 Chemical 95% 否
HY-B0174AS Olsalazine-13C6 Inducer / 否
HY-B0213S1 Sulfameter-13C6 Inhibitor / 否
HY-B0263S1 Thiabendazole-13C6 Inhibitor / 否
HY-B0273S1 Sulfadiazine-13C6 Inhibitor / 否
HY-B0335S1 Tolfenamic acid-13C6 Inhibitor 99.7% 否
HY-B0337S2 Sulfadimethoxine-13C6 Inhibitor / 否
HY-B0375S1 Argatroban-13C6 hydrochloride Inhibitor / 否
HY-B0467AS Amoxicillin-13C6 Inhibitor / 否
HY-B0497BS Niclosamide-13C6 monohydrate / 否
HY-B0512S1 Sulfamerazine-13C6 Inhibitor / 否
HY-B0574S2 Mefenamic acid-13C6 Inhibitor / 否
HY-B0822S1 Fipronil-13C6 / 否
HY-B0843S Metalaxyl-13C6 Inhibitor 98.4% 否
HY-B0946S2 Sulfamonomethoxine-13C6 Inhibitor / 否
HY-B0947S1 Sulfanitran-13C6 / 否
HY-B1355AS1 Oxyphenbutazone-13C6 Inhibitor / 否
HY-B1409S Isosorbide dinitrate-13C6 / 否
HY-B1422S 9-Aminoacridine-13C6 Inhibitor / 否
HY-B1436S1 Nifuroxazide-13C6 Inhibitor / 否
HY-B1456AS Fenoprofen-13C6 sodium hydrate / 否
HY-B1779S5 Sucrose-13C6 / 否
HY-B1781S Sulfachloropyridazine-13C6 Inhibitor / 否
HY-B2156S1 Menaquinone-4-13C6 / 否
HY-B2236S1 DL-Lysine-13C6 hydrochloride / 否
HY-B2236S2 DL-Lysine-13C6,15N2 hydrochloride / 否
HY-D1433 FITC-C6-LEHD-FMK / 否
HY-D1573 C6 NBD Phytoceramide / 否
HY-D1749 C6 NBD L-threo-ceramide / 否
HY-E70037 GlcNAc kinase (EcNagK) / 否
HY-E70163 Carbohydrate Sulfotransferase 3 / 否
HY-E70164 Carbohydrate Sulfotransferase 4 / 否
HY-N0086S3 N6-Methyladenosine-13C3 Inhibitor / 否
HY-N0379S18 D-Mannose-13C6,d7 / 否
HY-N0470S1 L-Lysine-13C6,15N2,d9 dihydrochloride Inhibitor / 否
HY-N0771S5 L-Isoleucine-13C6,15N,d10 / 否
HY-N0832S1 L-Histidine-13C6,15N3 Inhibitor / 否
HY-N0832S1A L-Histidine-13C6,15N3 hydrochloride / 否
HY-N10192 Aculene D Inhibitor / 否
HY-N11137 3′-Omethyl-5′-hydroxydiplacone Inhibitor / 否
HY-N1127S Tricin-d6 / 否
HY-N12396 Cyclosporin U / 否
HY-N1380S2 Guaiacol-13C6 / 否
HY-N1393S 2-Methoxybenzoic acid-13C6 / 否
HY-N1394S p-Anisic acid-13C6 Inhibitor / 否
HY-N15932 C6(6-Azido) LacCer / 否
HY-N15944 C6(6-Azido) GluCer / 否
HY-N15946 Photoclick C6 ceramide / 否
HY-N15961 C6(6-Azido) GalCer / 否
HY-N16325 Golgi-laurdan / 否
HY-N7092S13 D-Fructose-13C6,d7 / 否
HY-N7106S2 Dimethyl phthalate-13C6,d4 / 否
HY-N7106S3 Dimethyl phthalate-13C6 / 否
HY-N7123S1 Sulfacetamide-13C6 Inhibitor / 否
HY-N7147 Irisquinone / 否
HY-N7464 Jolkinolide E / 否
HY-N7745S2 Glucosylsphingosine-13C6 / 否
HY-N8462 6-O-Nicotinoylscutebarbatine G / 否
HY-N8588 Methyl ganoderate C6 / 否
HY-P0206S RPPGFSPF-(Arg-13C6,15N) TFA / 否
HY-P11199S IVLIGNAGVG-(Lys-13C6,15N2) / 否
HY-P2625S GLP-2(3-33) (Leu-13C6,15N) / 否
HY-P2625S1 GLP-2(3-33) (Leu-13C6,15N) TFA Agonist / 否
HY-P4473S H-Phe-Ile-OH-13C6,15N TFA / 否
HY-P4596S H-Gly-Arg-OH (Arg-13C6,15N4) / 否
HY-P4596S1 H-Gly-Arg-OH (Arg-13C6,15N4) TFA / 否
HY-P5168AS GPSVFPLAPSSK-13C6,15N2 TFA Inhibitor / 否
HY-P5190S RQIK-(Lys-fructosyl)-QTA-(Leu-13C6,15N)-VE / 否
HY-P5190S1 RQIK-(Lys-fructosyl)-QTA-(Leu-13C6,15N)-VE TFA / 否
HY-P5201S VTSEGAGLQLQK-13C6,15N2 / 否
HY-P5201S1 VTSEGAGLQLQK-13C6,15N2 TFA / 否
HY-P5628 Termicin / 否
HY-P6421S LGPLVEQG-Arg(13C6,15N4) TFA / 否
HY-P6422S LAVYQAGA-Arg(13C6,15N4) TFA / 否
HY-P6423S CLAVYQAGA-Arg(13C6,15N4) TFA / 否
HY-P6424S LGADMEDVCG-Arg(13C6,15N4) TFA / 否
HY-RS01752 C6 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS05970 H3C6 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS05978 H4C6 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS11297 PSMA7 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-W001138S 4-Bromobenzaldehyde-13C6 / 否
HY-W007318S 2-Iodoaniline-13C6 / 否
HY-W007527S 4-Bromo-2-chlorophenol-13C6 / 否
HY-W008253S3 5-Hydroxyindole-3-acetic acid-13C6 / 否
HY-W008452S H-Tyr(3-I)-OH-13C6 / 否
HY-W008642S (Leu-13C6,15N)-Leu-OH TFA / 否
HY-W009048 Dicyclohexano-18-crown-6-ether 97.0% 否
HY-W009300S1 4-Hydroxyestrone-13C6 / 否
HY-W009597S 1,5-Dichloro-2,4-dinitrobenzene-13C6 99% 否
HY-W010696AS Reverse T3-13C6 hydrochloride 96% 否
HY-W013186S1 Lansoprazole sulfide-13C6 / 否
HY-W013396S 4-Iodobenzoic Acid-13C6 / 否
HY-W013677S 4-Fluorobenzoic acid-13C6 / 否
HY-W014223S 2,4-Dihydroxybenzophenone-13C6 / 否
HY-W014375S1 DL-Arginine-13C6,15N4,d7 hydrochloride / 否
HY-W014531S 2,6-Dichloro-4-nitrophenol-13C6 / 否
HY-W014632S 4-Trifluoromethylsalicylic acid-13C6 / 否
HY-W017401S Benzisothiazolinone-13C6 Inhibitor / 否
HY-W017529S 6-Chloro-1,3,5-triazine-2,4-diamine-13C3 / 否
HY-W018386S 3-​Bromo-​L-​tyrosine-13C6 / 否
HY-W069721S1 N-Acetylsulfanilamide-13C6 / 否
HY-W074977S 2,6-Dibromo-4-nitrophenol-13C6 / 否
HY-W092298S Methyl 4-(2-hydroxyethyl)benzoate-13C6,d2 / 否
HY-W100312S o-Toluidine-13C6 hydrochloride / 否
HY-W106014S [1,1'-Biphenyl]-3-amine-13C6 hydrochloride / 否
HY-W156511S Diacetylsulfanilamide-13C6 / 否
HY-W243018S 1,2:5,6-Di-O-isopropylidene-a-D-glucofuranose-1,2,3,4,5,6-13C6 / 否
HY-W269700S Ile-(Leu-13C6,15N)-OH TFA / 否
HY-W278861S Desoxy-Mequindox-13C6 / 否
HY-W280531S DNSAH-13C6 99.98% 否
HY-W344468S Adipate-13C6 sodium / 否
HY-W584531 VH032-C6-NH-Boc / 否
HY-W653738 2,4,5,6-Tetrachlorophenol-13C6 / 否
HY-W653798 Hexachlorobenzene-13C6 / 否
HY-W654109 2-Chloroanthracene-13C6 / 否
HY-W654206 D-Glucose 6-Phosphate Sodium Salt Hydrate-13C6 / 否
HY-W739894S Diclofenac metabolite-13C6 / 否
HY-W747060 Benzyl 4-hydroxybenzoate-13C6 / 否
HY-W747879 Diclofenac Amide-13C6 / 否
HY-W748193 2,5-Furandicarboxylic acid-13C6 / 否
HY-W748418 1-Thio-β-D-glucose Sodium Salt Dihydrate-13C6 / 否
HY-W748540 N6-[(Allylamino]carbonothioyl]lysine-13C6,15N2 / 否
HY-W748541 N6-[(Benzylamino)carbonothioyl]lysine-13C6,15N2 / 否
HY-W748688 N4-Acetylsulfamethoxazole-13C6 / 否
HY-W749012 (2,4,6-Trichlorophenoxy)acetic acid-13C6 / 否
HY-W749198 1,2,4-Trimethyl benzene-13C6 / 否
HY-W749199 2-Ethyl toluene-13C6 / 否
HY-W749377 1,2,3,4,5-Pentabromo-6-methylbenzene-13C6 / 否
HY-W749378 1,2,3,4,5-Pentabromo-6-ethylbenzene-13C6 / 否
HY-W749528 3-Deoxyglucosone-13C6 / 否
HY-W749598 N-Methoxy-N-methylnicotinamide-13C6 / 否
HY-W749645 Acrolein 2,4-Dinitrophenylhydrazone-13C6 / 否
HY-W750212 Acid Orange 7-13C6 / 否
HY-W750294 δ-Hexachlorocyclohexane-13C6 / 否
HY-W750399 4,5,6,7-Tetrabromoisobenzofuran-1,3-dione-13C6 / 否
HY-W750442 4-Bromophenoxytriisopropylsilane-13C6 / 否
HY-W750443 4-Bromophenol-1,2,3,4,5,6-13C6 / 否
HY-W750888 (Z)-Chlorolefin-13C6 / 否
HY-W751179 Midostaurin-13C6 / 否
HY-W751180 3-Hydroxy Midostaurin-13C6 / 否
HY-W751181 O-Desmethyl midostaurin-13C6 / 否
HY-W751444 2,4-Dimethylanisole-13C6 / 否
HY-W751475 1-(Methoxymethoxy)benzene-13C6 / 否
HY-W751526 N4-Acetylsulfamethazine-13C6 / 否
HY-W751537 4-[[(4-Fluorophenyl)imino]methyl]phenol-13C6 / 否
HY-W751834 6-Amino-5-nitropyrimidine-2,4(1H,3H)-dione-13C3 / 否
HY-W751917 Aniline-13C6 hydrochloride / 否
HY-W752253 N-2-Naphthalenyl-N-phenyl-2-naphthalenamine-13C6 / 否
HY-W753343 2-Chloro-N-phenylacetamide-13C6 / 否
HY-W753344 2-(2,6-Dichlorophenoxy)-N-phenylacetamide-13C6 / 否
HY-W753345 2,6-Dichlorodiphenylamine-13C6 / 否
HY-W753370 2,4,5-Trichloronitrobenzene-13C6 / 否
HY-W754216 Diacetone-β-D-fructose-13C6 / 否
HY-W754400 Mannosan,95%-13C6 / 否
HY-W754982 N-Cyclohexyl-1,3-benzothiazol-2-amine-13C6 / 否
HY-W755778 3-Iodothyronamine hydrochloride-13C6 / 否
HY-W756637 Ibufenac-13C6 / 否
HY-W766332 7-Hydroxy coumarin glucuronide sodium-13C6 / 否
HY-W766388 2-Amino-2-deoxyglucose hydrochloride-13C6 / 否
HY-W766699 6-Amino-4-hydroxy-2-mercaptopyrimidine-13C / 否
HY-W767285 6-Amino-5-nitrosouracil-13C2 / 否
HY-W768181 1,5-Anhydrosorbitol-13C6 / 否
HY-W768211 2-Deoxy-2-fluoro-D-glucose-13C6 / 否
HY-W768246 Galactose 1-phosphate-13C6 potassium / 否
HY-W768262 D-(+)-Glucono-1,5-lactone-13C6 / 否
HY-W768295 D-Lactose monohydrate-13C6 / 否
HY-W768427 2,4,5-Trichlorophenol-13C6 / 否
HY-W768912 Paclitaxel-13C6 / 否
HY-W768934 L-Gulono-1,4-lactone-13C6 / 否
HY-W769361 5-Hydroxymethyl-2-furancarboxylic acid-13C6 / 否
HY-W770176 2-Benzyl-5-chlorobenzaldehyde-13C6 / 否
HY-W770294 3,4,5,6-Tetrabromophthalic acid-13C6 / 否
HY-W770721 Phenylboronic acid-13C6 / 否
HY-W770952 DL-Phenylmercapturic Acid-13C6 / 否
HY-W771036 Argininic acid-13C6 / 否
HY-W771037 2-Oxoarginine-13C6 / 否
HY-W771072 4-Hydroxybenzenesulfonic Acid-13C6 / 否
HY-W776938 Ethyl nicotinate hydrochloride-13C6 / 否
HY-W777188 6-Hydroxy Chlorzoxazone-13C6 / 否
HY-W777334 2,5-Dioxopyrrolidin-1-yl nicotinate-13C6,d4 / 否
HY-W777393 Umbelliferone-13C6 / 否
HY-W777439 4-Chloro-6-nitrosoresorcinol-13C6 / 否
HY-W777440 4-Chloro resorcinol-13C6 / 否
HY-W777456 Phenanthrene-13C6 / 否
HY-W777457 Anthracene-13C6 / 否
HY-W777458 Fluorene-13C6 / 否
HY-W777477 Homovanillic Acid-13C6 / 否
HY-W777496 Saccharin-13C6 / 否
HY-W777526 Nitisinone-13C6 / 否
HY-W777534 4-Acetamidobenzene-1-sulfonyl chloride-13C6 / 否
HY-W777535S Naphthalene-13C6 / 否
HY-W777546 (5-Formylfuran-2-yl)methyl acetate-13C6 / 否
HY-W777581 4-tert-Octylphenol-diethoxylate-13C6 / 否
HY-W777582 4-tert-Octylphenol monoethoxylate-13C6 / 否
HY-W777823 N-(a,a-Dimethylbenzyl)benzenesulfonamide-13C6 / 否
HY-W777928 Cyclohexane-1,3-dione-13C6 / 否
HY-W778065 N-(tert-Butoxycarbonyl)aniline-13C6 / 否
HY-W778171 2-Benzyloxy-5-nitro-benzoic Acid Benzyl Ester-13C6 / 否
HY-W778172 2-Benzyloxy-3-nitro-benzoic Acid Benzyl Ester-13C6 / 否
HY-W778173 2-Benzyloxy-benzoic Acid Benzyl Ester-13C6 / 否
HY-W778240 2-Naphthoic acid-13C6 / 否
HY-W778242 3,4-Dihydronaphthalen-1-one-13C6 / 否
HY-W778408 Tamoxifen-13C6 / 否
HY-W779969 2-Acetyl-4-tetrahydroxybutyl imidazole-13C6 / 否
HY-W780293 2-Phenylphenol-13C6 / 否
HY-W800777 6-(3-Hydroxypropylamino)hexyl 2-hexyldecanoate / 否
HY-Y0535S Pyrocatechol-13C6 / 否
HY-Y0589S m-Cyanobenzoic acid-13C6 / 否
HY-Y0721S 3-Bromofluorobenzene-13C6 / 否
HY-Y0931S 3-Iodobenzoic Acid-13C6 / 否
HY-Y1152S Fluorobenzene-13C6 / 否
HY-Y1636S Fmoc-Arg(Pbf)-OH-13C6,15N4 / 否
HY-101277S1 Vadadustat-13C6 Inhibitor / 否
HY-10268S2 Betrixaban-13C6 / 否
HY-10574S1 Rilpivirine-13C6 Inhibitor / 否
HY-113046S1 5-Methyltetrahydrofolic acid-13C6 / 否
HY-114667 Lavendustin C6 Inhibitor / 否
HY-121267S Dicamba-13C6 / 否
HY-12767S2 Carvedilol metabolite 4-Hydroxyphenyl Carvedilol-13C6 / 否
HY-128417S4 alpha-D-glucose-13C6 / 否
HY-128417S5 alpha-D-glucose-13C6,d7 / 否
HY-129503S 2-Heptyl-4-quinolone-13C6 / 否
HY-13017S4 Ivacaftor-13C6 Agonist / 否
HY-132274 DMS(O)MT aminolink C6 / 否
HY-13458S2 Droxidopa-13C6 / 否
HY-13553S1 Anidulafungin-13C6 Inhibitor / 否
HY-137222S 4',5-Dihydroxy Diclofenac-13C6 Inhibitor / 否
HY-137522AS1 Zidovudine Glucuronide-13C6 / 否
HY-13966S3 2-Deoxy-D-glucose-13C6 / 否
HY-14171S2 Bexarotene-13C6 / 否
HY-143679S 4-(3',6'-Dimethyl-3'-heptyl)phenol diethoxylate-13C6 / 否
HY-143704S 5-Aminosalicylic acid-13C6 hydrochloride 99.53% 否
HY-143857S 22:0 Lyso PC-13C6 / 否
HY-14397S3 Indomethacin-13C6 Inhibitor / 否
HY-145517 C6-Phytoceramide Inducer / 否
HY-14740S2 Elvitegravir-13C6 Inhibitor / 否
HY-14832S1 Ataluren-13C6 Inhibitor / 否
HY-149563 Thalidomide-5-O-C6-NH2 hydrochloride / 否
HY-150194S Fructose-glutamic acid-13C6 / 否
HY-150679S Remdesivir-13C6 / 否
HY-151792 Pomalidomid-C6-PEG3-butyl-N3 / 否
HY-15206S2 Glibenclamide-13C6 / 否
HY-15388S2 Tazarotene-13C6 Agonist / 否
HY-15409S1 Empagliflozin-13C6 / 否
HY-158656 3-Keto sphinganine (d6:0) hydrochloride / 否
HY-159077 H2N-C6-NH-CO-CH2-O-Ph-CH2-NH-Boc / 否
HY-161538 Lenalidomide-C6-Br / 否
HY-163992S VTMTRDTSISTAYMELSR-(Ile-13C6,15N) / 否
HY-163993S GMDRWGQGTLVTVSS-(Leu-13C6,15N) / 否
HY-165087 C6 Biotin ceramide (d18:1/6:0) / 否
HY-165975 (2S)-3-Keto sphinganine (d6:0) (hydrochloride) / 否
HY-166282 C6 NBD-L-threo-dihydrosphingosine / 否
HY-16637S5 Folic acid-13C6 / 否
HY-168132 Thalidomide-NH-C-C6H10-C-acid / 否
HY-168291 Thalidomide-NH-CH2-CONH-C6-Br / 否
HY-17007S2 Saquinavir-13C6 / 否
HY-17043S3 Loratadine-13C6 / 否
HY-172361 Thalidomide-F-NH-C6-adize / 否
HY-173085S TPPSSGEPPK-(Lys-13C6,15N2) TFA / 否
HY-173086S TPSLPTPPTR-(Arg-13C6,15N4) TFA / 否
HY-173087S TPPSSGEPPKSGDR-(Arg-13C6,15N4) TFA / 否
HY-173088S IPAK(pT)PPAPK-(Lys-13C6,15N2) TFA / 否
HY-173089S TPSLP(pT)PP(pT)REPK-(Lys-13C6,15N2) TFA / 否
HY-173090S VAVVR(pT)PPK(pS)PSSAK-(Lys-13C6,15N2) TFA / 否
HY-173091S pyroE-QEAVEGGC(Cam)SHLGQSYADR-(Arg-13C6,15N4) TFA / 否
HY-173098S YLPNPA(Leu-13C6,15N)QR TFA / 否
HY-173099S GNSP(Ile-13C6,15N)SQR TFA / 否
HY-173100S GIFP(Leu-13C6,15N)AER TFA / 否
HY-173101S GHFP(Leu-13C6,15N)AER TFA / 否
HY-173104S SLPAS(Leu-13C6,15N)QR TFA / 否
HY-173106S YTASD(Leu-13C6,15N)FR TFA / 否
HY-17356S2 Fenofibrate-13C6 / 否
HY-17359S1 Deferasirox-13C6 Inhibitor / 否
HY-17405S Alarelin-(Leu-13C6,15N) TFA / 否
HY-17430S2 Amprenavir-13C6 Inhibitor / 否
HY-17498S3 Atenolol-13C6 Antagonist / 否
HY-175413 FTAC6 / 否
HY-176032S GPAAGPQGP-Arg(13C6,15N4) TFA / 否
HY-176102 C6 Ceramide (d18:1/6:0) alkyne / 否
HY-176177S DEKM(Leu-13C6,15N)VLWVVALSGISTLFFAA / 否
HY-176178S LFVFAVCFSCWV(Leu-13C6,15N)PQGQYGR / 否
HY-176348S Choriogonadotropin, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176350S Erythropoietin, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-176816 C6 1-Deoxyceramide (m18:1/6:0) / 否
HY-176818 C6 1-Deoxyceramide (m18:1(14Z)/6:0) / 否
HY-18342S1 Diflunisal-13C6 Inhibitor / 否
HY-19542A N-Hexanoyl-L-erythro-sphingosine / 否
HY-19821S1 Fmoc-Ile-OH-13C6,15N 99.90% 否
HY-76520S Sitaxsentan-13C6 Antagonist / 否
HY-78726S2 Fosamprenavir-13C6 Inhibitor / 否
HY-79128S1 Fmoc-L-Lys (Boc)-OH-13C6,15N2 Inhibitor 99.90% 否
HY-B0083S1 Leflunomide-13C6 Inhibitor / 否
HY-B0122SS1 Topiramate-13C6-1 / 否
HY-B0124S2 Zonisamide-13C6 Inhibitor / 否
HY-B0149S2 Tranexamic acid-13C6 / 否
HY-B0152S3 Adenine-13C5 Chemical / 否
HY-B0211S1 Riluzole-13C6 Inhibitor / 否
HY-B0227S3 Ketoprofen-13C6 Inhibitor / 否
HY-B0363S1 Nimesulide-13C6 Inhibitor / 否
HY-B0411S2 Domperidone-13C6 Inhibitor / 否
HY-B0482S1 Acemetacin-13C6 Inhibitor / 否
HY-B0580S2 Ketorolac-13C6 / 否
HY-B0637S2 Bezafibrate-13C6 Agonist / 否
HY-B0945S Nitromide-13C6 / 否
HY-B1125S Glucosamine-13C6 / 否
HY-B1190S2 Cefadroxil-13C6 / 否
HY-B1374S2 Florfenicol-13C6 Inhibitor / 否
HY-B1941S1 4-tert-Octylphenol-13C6 / 否
HY-D1576 C6 NBD L-threo-dihydroceramide / 否
HY-N0086S2 N6-Methyladenosine-13C4 Inhibitor 99.8% 否
HY-N10004S Fructose-proline-13C6 / 否
HY-N3622 Corchoionoside C / 否
HY-P0119S Lixisenatide (Leu-13C6,15N) TFA / 否
HY-P3207S DLPLTFGGGT-Lys-13C6,15N2 TFA / 否
HY-P5168S GPSVFPLAPSSK-13C6,15N2 Inhibitor / 否
HY-P6425S LCADMEDV-Arg(13C6,15N4) TFA / 否
HY-RS16809 C6 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS23249 C6 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-W008125S Acetobromo-a-D-glucuronic acid-13C6 methyl ester / 否
HY-W008614S1 Lansoprazole sulfone-13C6 Inhibitor / 否
HY-W010209S DL-Histidine-13C6,15N3 / 否
HY-W011577S1 Dibenzo[a,c]anthracene-13C6 / 否
HY-W012507S1 2,6-Dichlorobenzoic acid-13C6 / 否
HY-W014423S1 L-Histidine-13C6,15N3,d5 hydrochloride hydrate / 否
HY-W016814S (Z)-Aconitic acid-13C6 / 否
HY-W018587S TBPH-13C6,d34 / 否
HY-W020678S 2-Methylbutanal-13C2 / 否
HY-W024986S 4-(4-Hexoxyphenyl)benzonitrile-13C6 / 否
HY-W050154S Kojic acid-13C6 Inhibitor / 否
HY-W097410S1 2-Iodo-N-phenylacetamide-13C6 / 否
HY-W1008621 GalNAc-THA C6 phosphoramidite / 否
HY-W101298S (Leu-13C6,15N)-Ile-OH TFA / 否
HY-W104549S 3,6-Dichloro-2-hydroxybenzoic acid-13C6 99.0% 否
HY-W140740S Hexabromobenzene-13C6 / 否
HY-W145482S1 3-O-Methyl-D-glucopyranose-13C6 / 否
HY-W245946 Hexyl bromide / 否
HY-W337886S 2-Ethylhexyl 2,3,4,5-tetrabromobenzoate-13C6,d17 / 否
HY-W369135 TFA-Hexylaminolinker Phosphoramidite / 否
HY-W585890S Benzo[pqr]tetraphen-3-ol-13C6 / 否
HY-W585933S Fructose-alanine-13C6 / 否
HY-W585934S Fructose-phenylalanine-13C6 / 否
HY-W590539 ω-azido-C6 Ceramide Inhibitor / 否
HY-W590666 N-Hexanoyldihydrosphingosine / 否
HY-W591352 Thalidomide-5-(C6-amine) / 否
HY-W591973 OTs-C6-NHBoc / 否
HY-W653832 Phenol-13C6 / 否
HY-W654082 Bisphenol e-13C6 / 否
HY-W715199S Pentabromo benzene-13C6 / 否
HY-W721295S N-(1-Deoxy-D-fructos-1-yl)-L-methionine-13C6 / 否
HY-W738582S N-(1-Deoxy-D-fructos-1-yl)​-L-threonine-13C6 / 否
HY-W746828 Oxindole-3-acetic acid-13C6 / 否
HY-W747703 Hippuric acid-13C6 / 否
HY-W766368 C6 Ceramide-13C2,d2 / 否
HY-W770295 2,3,4,5-Tetrabromobenzoic acid-13C6 / 否
HY-W777418 Isosorbide mononitrate-13C6 Inhibitor / 否
HY-W777533 N-Acetyl sulfadiazine-13C6 / 否
HY-W777583 2-[4-(1-Ethyl-1,4-dimethylpentyl)phenoxy]ethanol-13C6 / 否
HY-W777681 Triflusal-13C6 / 否
HY-W777964 Phloroglucinol-13C6 / 否
HY-W779345 Reverse T3-13C6 / 否
HY-W780150 1-Bromobenzene-13C6 / 否
HY-W793608S N-(1-Deoxy-D-fructos-1-yl)-L-asparagine-13C6 / 否
HY-W800740 Nonyl 6-bromohexanoate / 否
HY-W800742 Heptadecan-9-yl 6-bromohexanoate / 否
HY-W800743 Heptyl 6-bromohexanoate / 否
HY-W800829 S-Undecyl 6-bromohexanethioate / 否
HY-Y1027S1 2-Chlorobenzoic acid-13C6 / 否
HY-Y1636S1 Fmoc-Arg(Pbf)-OH-13C6 / 否
HY-111543 AN11251 Inhibitor / 否
HY-101009 Methiothepin maleate Antagonist / 否
HY-111491 Methiothepin Antagonist / 否
HY-111824 VH032-thiol-C6-NH2 / 否
抗体抑制剂 (1)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P99832 Cosfroviximab 95.00% 否

直系同源

种属 基因名 来源 基因 ID
Bos taurus C6 VGNC VGNC:52722
Felis catus C6 VGNC VGNC:60233
Rattus norvegicus C6 RGD RGD:2238
Canis familiaris C6 VGNC VGNC:38598
Macaca mulatta C6 VGNC VGNC:70477
Mus musculus C6 MGD MGI:88233
Macaca fascicularis C6 NCBI NCBI:102116032
Others C6 NCBI
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z